These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15055909)

  • 1. Immunopathogenesis of multiple sclerosis: implications for treatment.
    Waldron-Lynch F; Hennessy MJ
    Ir Med J; 2004 Jan; 97(1):5-6. PubMed ID: 15055909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multiple sclerosis: from immunopathogenesis to disease management].
    Nervenarzt; 1996 Dec; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study.
    Cooper SM; Ali I; Baldo M; Wojnarowska F
    Arch Dermatol; 2008 Nov; 144(11):1432-5. PubMed ID: 19015417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of juvenile systemic sclerosis in Japanese.
    Murata M; Sato S; Komura K; Shirasaki F; Hasegawa M; Takehara K
    J Rheumatol; 2005 Sep; 32(9):1850-2. PubMed ID: 16142890
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece.
    Deretzi G; Kountouras J; Koutlas E; Zavos C; Polyzos S; Rudolf J; Grigoriadis N; Gavalas E; Boziki M; Tsiptsios I
    Mult Scler; 2010 Sep; 16(9):1091-101. PubMed ID: 20639270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and progression in multiple sclerosis.
    Koch M; van Harten A; Uyttenboogaart M; De Keyser J
    Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and epileptic seizures.
    Catenoix H; Marignier R; Ritleng C; Dufour M; Mauguière F; Confavreux C; Vukusic S
    Mult Scler; 2011 Jan; 17(1):96-102. PubMed ID: 20861180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diversity of systemic connective tissue disorders].
    Julkunen H; Ekblom-Kullberg S
    Duodecim; 2004; 120(15):1876-83. PubMed ID: 15508761
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL
    Arch Neurol; 2004 Oct; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute presentation of mania.
    Ball SC
    AIDS Read; 2005 Mar; 15(3):118-20, 126-7. PubMed ID: 15786573
    [No Abstract]   [Full Text] [Related]  

  • 11. [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].
    Aleksandrowicz J; Blicharski J; Skotnicki A; Retinger M; Zduńczyk A
    Pol Tyg Lek; 1981 Aug; 36(35):1363-5. PubMed ID: 7036112
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey.
    Nicoletti A; Patti F; Lo Fermo S; Messina S; Bruno E; Quattrocchi G; Laisa P; Cilia S; Mostile G; Marziolo R; Scillieri R; Maimone D; Zappia M
    Mult Scler; 2011 Mar; 17(3):273-80. PubMed ID: 21071466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple sclerosis].
    Offenhäusser M; Martin R
    Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.
    Gray OM; McDonnell GV; Hawkins SA
    Mult Scler; 2008 Aug; 14(7):880-6. PubMed ID: 18573832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vogt-Koyanagi-Harada disease in Thai patients.
    Tesavibul N; Sansanayuth W
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at onset determines the occurrence of the progressive phase of multiple sclerosis.
    Stankoff B; Mrejen S; Tourbah A; Fontaine B; Lyon-Caen O; Lubetzki C; Rosenheim M
    Neurology; 2007 Mar; 68(10):779-81. PubMed ID: 17339588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course].
    Henneberg A; Mayle DM; Pfau JU; Hartmann P; Elsner U; Kornhuber HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):593-6. PubMed ID: 7856267
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
    Beutler E; Sipe J; Romine J; McMillan R; Zyroff J; Koziol J
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):45-52. PubMed ID: 8714617
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients.
    Putzki N; Katsarava Z; Vago S; Diener HC; Limmroth V
    Eur Neurol; 2008; 59(3-4):136-42. PubMed ID: 18057900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stem cell transplantations as a treatment of severe autoimmune diseases].
    Jantunen E; Myllykangas-Luosujärvi R; Kaipiainen-Seppänen O; Mahlamäki E; Nousiainen T
    Duodecim; 2000; 116(7):721-7. PubMed ID: 12078138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.